
Keywords: Peptidomimetic boronates; Proteasome inhibitors; Docking studies; ChT-L; chymotrypsin-like; T-L; trypsin-like; PGPH; post-glutamyl peptide hydrolyzing; DMSO; dimethyl sulfoxide; DMF; dimethylformamide; Pd2(dba)3; tris(benzylideneacetone)dipalladium; EDC;